Long-Term Effect of 17 -Estradiol and Thrombin on Tissue Factor Pathway Inhibitor Release from HUVEC *

Author： Bilsel A.S. Onaran N. Moini H. Emerk K.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.99, Iss.2, 2000-07, pp. : 173-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The tethered ligand receptor is the responsible receptor for the thrombin induced release of von willebrand factor from endothelial cells (HUVEC)

By Storck J. Kusters B. Zimmermann E.R.

Thrombosis Research, Vol. 77, Iss. 3, 1995-02 ,pp. : 249-258

Elsevier

Access to resources Recommend Favorite

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism

By Erem Cihangir

Endocrine Journal, Vol. 35, Iss. 1, 2009-02 ,pp. : 75-80

Humana Press, Inc

Access to resources Recommend Favorite

Tissue Factor Pathway Inhibitor Endocytosis

By Schwartz A.L. Broze G.J.

Trends in Cardiovascular Medicine, Vol. 7, Iss. 7, 1997-10 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite

Endogenous Release of Tissue Factor Pathway Inhibitor by Topical Application of an Ointment Containing Mucopolysaccharide Polysulfate to Nonhuman Primates

By Hoppensteadt D.A. Fareed J. Raake P. Raake W.

Thrombosis Research, Vol. 103, Iss. 2, 2001-07 ,pp. : 157-163

Elsevier

Access to resources Recommend Favorite

Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture

By Stasko J. Drouet L. Soria C. Mazoyer E. Caen J. Kubisz P.

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 161-164

Elsevier

Access to resources Recommend Favorite